Literature DB >> 15987753

Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.

Ivan C Moura1, Michelle Arcos-Fajardo, Abdelaziz Gdoura, Valérie Leroy, Charlotte Sadaka, Nizar Mahlaoui, Yves Lepelletier, François Vrtovsnik, Elie Haddad, Marc Benhamou, Renato C Monteiro.   

Abstract

IgA nephropathy (IgAN), the most common primary glomerulonephritis in the world, is characterized by IgA immune complex-mediated mesangial cell proliferation. The transferrin receptor (TfR) was identified previously as an IgA1 receptor, and it was found that, in biopsies of patients with IgAN, TfR is overexpressed and co-localizes with IgA1 mesangial deposits. Here, it is shown that purified polymeric IgA1 (pIgA1) is a major inducer of TfR expression (three- to four-fold increase) in quiescent human mesangial cells (HMC). IgA-induced but not cytokine-induced HMC proliferation is dependent on TfR engagement as it is inhibited by both TfR1 and TfR2 ectodomains as well as by the anti-TfR mAb A24. It is dependent on the continued presence of IgA1 rather than on soluble factors released during IgA1-mediated activation. In addition, pIgA1-induced IL-6 and TGF-beta production from HMC was specifically inhibited by mAb A24, confirming that pIgA1 triggers a TfR-dependent HMC activation. Finally, upregulation of TfR expression induced by sera from patients with IgAN but not from healthy individuals was dependent on IgA. It is proposed that deposited pIgA1 or IgA1 immune complexes could initiate a process of auto-amplification involving hyperexpression of TfR, allowing increased IgA1 mesangial deposition. Altogether, these data unveil a functional cooperation between pIgA1 and TfR for IgA1 deposition and HMC proliferation and activation, features that are commonly implicated in the chronicity of mesangial injuries observed in IgAN and that could explain the recurrence of IgA1 deposits in the mesangium after renal transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987753     DOI: 10.1681/ASN.2004111006

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  32 in total

Review 1.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

3.  Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia.

Authors:  Séverine Coulon; Michaël Dussiot; Damien Grapton; Thiago Trovati Maciel; Pamella Huey Mei Wang; Celine Callens; Meetu Kaushik Tiwari; Saurabh Agarwal; Aurelie Fricot; Julie Vandekerckhove; Houda Tamouza; Yael Zermati; Jean-Antoine Ribeil; Kamel Djedaini; Zeliha Oruc; Virginie Pascal; Geneviève Courtois; Bertrand Arnulf; Marie-Alexandra Alyanakian; Patrick Mayeux; Tomas Leanderson; Marc Benhamou; Michel Cogné; Renato C Monteiro; Olivier Hermine; Ivan C Moura
Journal:  Nat Med       Date:  2011-10-23       Impact factor: 53.440

Review 4.  Role of IgA and IgA fc receptors in inflammation.

Authors:  Renato C Monteiro
Journal:  J Clin Immunol       Date:  2009-10-16       Impact factor: 8.317

5.  Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.

Authors:  Laureline Berthelot; Thomas Robert; Vincent Vuiblet; Thierry Tabary; Antoine Braconnier; Moustapha Dramé; Olivier Toupance; Philippe Rieu; Renato C Monteiro; Fatouma Touré
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

6.  Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy.

Authors:  Grazia Serino; Fabio Sallustio; Sharon N Cox; Francesco Pesce; Francesco P Schena
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

Review 7.  The pathophysiology of IgA nephropathy.

Authors:  Hitoshi Suzuki; Krzysztof Kiryluk; Jan Novak; Zina Moldoveanu; Andrew B Herr; Matthew B Renfrow; Robert J Wyatt; Francesco Scolari; Jiri Mestecky; Ali G Gharavi; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

Review 8.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

Review 9.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

Review 10.  Role of IgA receptors in the pathogenesis of IgA nephropathy.

Authors:  Sebastian M Lechner; Christina Papista; Jonathan M Chemouny; Laureline Berthelot; Renato C Monteiro
Journal:  J Nephrol       Date:  2015-11-14       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.